HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,929,100 | -69.2% | 50,500 | -69.2% | 0.20% | -78.9% |
| Q1 2023 | $6,264,688 | -23.2% | 164,040 | +14.4% | 0.97% | -43.9% |
| Q4 2022 | $8,158,891 | +77.1% | 143,390 | +23.0% | 1.73% | +60.9% |
| Q3 2022 | $4,608,000 | +1.6% | 116,540 | +13.1% | 1.08% | -6.0% |
| Q2 2022 | $4,534,000 | +5.8% | 103,050 | -4.1% | 1.15% | +33.7% |
| Q1 2022 | $4,285,000 | +0.9% | 107,450 | +1.7% | 0.86% | +10.7% |
| Q4 2021 | $4,248,000 | +49.2% | 105,650 | +51.0% | 0.78% | +31.4% |
| Q3 2021 | $2,847,000 | -9.4% | 69,980 | +1.1% | 0.59% | -14.2% |
| Q2 2021 | $3,142,000 | +9.4% | 69,200 | +0.4% | 0.69% | +17.2% |
| Q1 2021 | $2,872,000 | – | 68,900 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |